AlphaGrep UK’s CME Group CME Stock Holding History

AlphaGrep UK’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-3,067	Closed	-$677K	–	783
2026 Q2	$677K	Buy	3,067 +2,108	+220%	+$583K	0.2%	128
2026 Q1	$283K	Sell	959 -1,730	-64%	-$514K	0.08%	542
2025 Q4	$734K	Buy	+2,689	New	+$731K	0.25%	88

Other funds holding CME

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $103B AUM 36.66% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

AlphaGrep UK's CME Position: Q3 2026 in Review

AlphaGrep UK sold out of CME Group (CME) in Q3 2026, closing a stake of 3,067 shares — an estimated $677K sold.

AlphaGrep UK first reported a position in CME in Q4 2025 and held it in 3 quarters. The position peaked at $734K in Q4 2025. 1,503 funds tracked by Wall St. Rank hold CME as of Q3 2026.

AlphaGrep UK reported no remaining CME Group position as of Q3 2026 after selling out during the quarter.
AlphaGrep UK sold 3,067 CME Group shares in Q3 2026, an estimated $677K.
AlphaGrep UK first reported a position in CME Group in Q4 2025 and held it in 3 quarters.
AlphaGrep UK's CME Group position peaked at $734K in Q4 2025.
1,503 funds tracked by Wall St. Rank held CME Group as of Q3 2026.

Based on AlphaGrep UK's 13F filing for Q3 2026, filed 12 Nov 2026.